A Potent Small-Molecule Inhibitor of the MDM2-p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice

被引:245
作者
Zhao, Yujun [1 ,2 ,3 ,4 ]
Yu, Shanghai [1 ,2 ,3 ,4 ]
Sun, Wei [1 ,2 ,3 ,4 ]
Liu, Liu [1 ,2 ,3 ,4 ]
Lu, Jianfeng [1 ,2 ,3 ,4 ]
McEachern, Donna [1 ,2 ,3 ,4 ]
Shargary, Sanjeev [1 ,2 ,3 ,4 ]
Bernard, Denzil [1 ,2 ,3 ,4 ]
Li, Xiaoqin [5 ]
Zhao, Ting [5 ]
Zou, Peng [5 ]
Sun, Duxin [5 ]
Wang, Shaomeng [1 ,2 ,3 ,4 ]
机构
[1] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
STRUCTURE-BASED DESIGN; P53; ANTAGONISTS; ACTIVATION; GROWTH; CANCER; DOMAIN;
D O I
10.1021/jm4005708
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We previously reported the discovery of a class of spirooxindoles as potent and selective small-molecule inhibitors of the MDM2-p53 interaction (MDM2 inhibitors). We report herein our efforts to improve their pharmacokinetic properties and in vivo antitumor activity. Our efforts led to the identification of 9 (MI-888) as a potent, MDM2 inhibitor (K-i = 0.44 nM) with a superior pharmacokinetic profile and enhanced in vivo efficacy. Compound 9 is capable of achieving rapid, of human cancer with oral administration and represents the most potent complete, and durable tumor regression in two types xenograft models and efficacious MDM2 inhibitor reported to date.
引用
收藏
页码:5553 / 5561
页数:9
相关论文
共 23 条
[1]   Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2-Tumor Protein 53 Protein-Protein Interaction [J].
Allen, John G. ;
Bourbeau, Matthew P. ;
Wohlhieter, G. Erich ;
Bartberger, Michael D. ;
Michelsen, Klaus ;
Hungate, Randall ;
Gadwood, Robert C. ;
Gaston, Rick D. ;
Evans, Bruce ;
Mann, Larry W. ;
Matison, Michael E. ;
Schneider, Stephen ;
Huang, Xin ;
Yu, Dongyin ;
Andrews, Paul S. ;
Reichelt, Andreas ;
Long, Alexander M. ;
Yakowec, Peter ;
Yang, Evelyn Y. ;
Lee, Tani Ann ;
Oliner, Jonathan D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (22) :7044-7053
[2]  
Bold G., 2011, PCT Int. Appl., Patent No. [WO 2011/023677, 2011023677, W02011023677A1]
[3]   Robust Generation of Lead Compounds for Protein-Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists [J].
Czarna, Anna ;
Beck, Barbara ;
Srivastava, Stuti ;
Popowicz, Grzegorz M. ;
Wolf, Siglinde ;
Huang, Yijun ;
Bista, Michal ;
Holak, Tad A. ;
Doemling, Alexander .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (31) :5352-5356
[4]   Structure-based design of potent non-peptide MDM2 inhibitors [J].
Ding, K ;
Lu, Y ;
Nikolovska-Coleska, Z ;
Qiu, S ;
Ding, YS ;
Gao, W ;
Stuckey, J ;
Krajewski, K ;
Roller, PP ;
Tomita, Y ;
Parrish, DA ;
Deschamps, JR ;
Wang, SM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (29) :10130-10131
[5]   Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction [J].
Ding, Ke ;
Lu, Yipin ;
Nikolovska-Coleska, Zaneta ;
Wang, Guoping ;
Qiu, Su ;
Shangary, Sanjeev ;
Gao, Wei ;
Qin, Dongguang ;
Stuckey, Jeanne ;
Krajewski, Krzysztof ;
Roller, Peter P. ;
Wang, Shaomeng .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) :3432-3435
[6]   Regulation of p53 downstream genes [J].
El-Deiry, WS .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :345-357
[7]   Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53 [J].
García-Echeverría, C ;
Chène, P ;
Blommers, MJJ ;
Furet, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (17) :3205-3208
[8]   Identification of the Spiro(oxindole-3,3′-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators [J].
Gomez-Monterrey, Isabel ;
Bertamino, Alessia ;
Porta, Amalia ;
Carotenuto, Alfonso ;
Musella, Simona ;
Aquino, Claudio ;
Granata, Ilaria ;
Sala, Marina ;
Brancaccio, Diego ;
Picone, Delia ;
Ercole, Carmine ;
Stiuso, Paola ;
Campiglia, Pietro ;
Grieco, Paolo ;
Ianelli, Pio ;
Maresca, Bruno ;
Novellino, Ettore .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (23) :8319-8329
[9]  
Hainaut P, 2000, ADV CANCER RES, V77, P81
[10]   Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-Activity Studies Leading to Improved Potency [J].
Hardcastle, Ian R. ;
Liu, Junfeng ;
Valeur, Eric ;
Watson, Anna ;
Ahmed, Shafiq U. ;
Blackburn, Timothy J. ;
Bennaceur, Karim ;
Clegg, William ;
Drummond, Catherine ;
Endicott, Jane A. ;
Golding, Bernard T. ;
Griffin, Roger J. ;
Gruber, Jan ;
Haggerty, Karen ;
Harrington, Ross W. ;
Hutton, Claire ;
Kemp, Stuart ;
Lu, Xiachong ;
McDonnell, James M. ;
Newell, David R. ;
Noble, Martin E. M. ;
Payne, Sara L. ;
Revill, Charlotte H. ;
Riedinger, Christiane ;
Xu, Qing ;
Lunec, John .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) :1233-1243